Dear Eagleye, what is about maximum target of Indovation Technologies Ltd. company share. Currently it is Rs.47.50/- what is target price within one month? Please share your knowledge on this.
As in banking stocks P/BV, is an important parameter, a look into P/BV, of listed peers as stated in rhp. CMP as on > B/V > P/BV 11/8/2016. Yes B 1252.5 > 327.26 > 3.83
IndusindB 1164.45 > 291.02> 4.0
Kotak B 764.65 > 181.86> 4.20
City u B 129.30 > 61.02> 2.12
Dev cr B 110.75 > 61.19> 1.81
If we take the P/BV median of highest 4.2 & lowest 1.81 =3.00, so RBL having bv of 92.02, i foresee listing around 275-280, hence current gmp seems justified.
SEPTA SIR EARLIER U SAID U WILL KEEP EQUITAS AS PORTFOLIO STOCK FOR 7 YR NOW U SAID U SOLD UJJIVAN AND EQUITAS ANYWAY RBL ANYTHING ABOVE 300 WILL BE EXIT PRICE
86.1. Septa| Link| Bookmark|
August 12, 2016 8:32:38 AM
(4000+ Posts, 4600+ Likes)
CA sahib I have trading portfolio and an investment portfolio on trading side I am out may buy again if u read my comment u will see I have said sold out holding free position which means the stock I now hold is free of cost will stay long in my investment portfolio. I hope u understand
86.2. Septa| Link| Bookmark|
August 12, 2016 8:37:31 AM
(4000+ Posts, 4600+ Likes)
also stock market is dynamic in nature when valuation froths up u book profit.... u can buy back
85. gamble| Link| Bookmark|
August 12, 2016 7:21:48 AM
(1600+ Posts, 3900+ Likes)
Yes i agree if issue opens @50 rs premium i.e 275 then it will commands PE of 27 i.e high. despite whatever the growth.
Though listing gain is sureshot because of such positivity created....
The main run starts of RBL after 1/2 yr....not sooner....so sell on listing and then buy on correction...before taking any move... I''m personally waiting for kostak to cross 1000rs first -:)
If Projeted eps of FY 17 is below 13 then issue is overpriced for short term(@275).only for listing gain in short or wait for 1/2 yr to see more gain.
85.1. Septa| Link| Bookmark|
August 12, 2016 9:18:19 AM
(4000+ Posts, 4600+ Likes)
Issue is high priced . Financial performence is not consistent.Doubtful if there are listing gains. Financials need a thorough analysis before taking an investment decision. On the face of it , it appears to be a risky investment.